Clinical trials: Peripheral Nueropathy Pain
Peripheral Nueropathy Pain
A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin
The purpose of this trial to compare the pharmacokinetic characteristics of YHD1119(Pregabalin 300mg) and Lyrica capsule(Pregabalin 150mg). YHD1119 is controlled release formulation which is made by Yuhan Corporation.
- Trial name
- NCT02783183
- Testing
- YHD1119, Lyrica
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Yuhan Corporation